| FDA Newswatch Today's News |
|---|
| US FDA Accepts for Priority Review Incyte BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal |
| 22 Jan 2021 12:00:00 UT |
| M2PHARMA-January 22, 2021-US FDA Accepts for Priority Review Incyte BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal - The US Food and Drug... |
| Canon Medical’s AI-powered, premium large bore CT receives FDA clearance |
| 23 Jan 2021 00:00:56 UT |
| TUSTIN, Calif.--(BUSINESS WIRE)--Canon Medical Systems USA, Inc. has received FDA clearance for the Aquilion Exceed LB™ CT system, giving clinicians the opportunity to see more during radiation... |
| FDA clears MULTIX Impact C ceiling-mounted DR system from Siemens Healthineers |
| 23 Jan 2021 00:00:56 UT |
| Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the MULTIX Impact C ceiling-mounted digital radiography (DR) system as well as the MULTIX Impact VA20, a new... |
| FDA Software Helps Prioritize COVID Vaccinations |
| 22 Jan 2021 23:36:00 UT |
| Regulatory Compliance / Coronavirus By in Chief Jan 22, 2021 An FDA data analysis tool has been offered to the national COVID-19 vaccination program to help prioritize food & beverage... |
| 11th-Hour Deal Strips FDA Oversight of Genetically Modified Animals |
| 22 Jan 2021 22:47:50 UT |
| This is the latest instance of Trump political appointees overriding the agency's scientists. The Health and Human Services Department has agreed to an industry-backed plan to effectively strip the... |
| FDA OKs Long-Acting Injectable Drug Regimen for HIV Treatment |
| 22 Jan 2021 22:39:04 UT |
| Cabotegravir and rilpivirine, injectable formulation is the first extended-release injectable drug regimen adults with HIV that is administered once per month, according to the FDA. It is indicated... |
| FDA Approves Fourth-Generation Deep Brain Stimulation System for Parkinson Disease Treatment |
| 22 Jan 2021 22:26:00 UT |
| The Food and Drug Administration (FDA) has approved a fourth-generation deep brain stimulation (DBS) system (Vercise Genus; Boston Scientific Corporation, Marlborough, MA). The DBS device is used to... |
| FDA Approves Cabenuva, First Long-Acting Injectable HIV Regimen |
| 22 Jan 2021 20:23:17 UT |
| Many people living with HIV will now be able to receive their treatment through a monthly injection rather than a daily pill. The U.S. Food and Drug Administration Thursday approved ViiV... |
| New First-Line Kidney Cancer Combination Gets FDA Nod |
| 22 Jan 2021 21:52:37 UT |
| WASHINGTON -- The FDA approved the combination of nivolumab (Opdivo) plus cabozantinib (Cabometyx) on Friday for treating advanced renal cell carcinoma (RCC) in the first-line setting. Support... |
| FDA clears J&J's robotic surgery system for total knee replacements |
| 22 Jan 2021 15:12:18 UT |
| Johnson & Johnson’s DePuy Synthes division has received FDA clearance for its robotic-assisted orthopedic surgical platform for total knee replacements. The Velys digital joint reconstruction... |
| rssfeedwidget.com |